Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India-Reference-Cited by-同舟云学术

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India

Published:2020-03 Issue:2 Volume:14 Page:e1-e13
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Puri Raman^ORCID,Mehta Vimal,Duell P. Barton,Nair Devaki,Mohan Jagdish Chander,Yusuf Jamal,Dalal Jamshed J.,Mishra Sundeep,Kasliwal Ravi R.,Agarwal Rajeev,Mukhopadhyay Saibal,Wardhan Harsh^ORCID,Khanna Narendra Nath^ORCID,Pradhan Akshaya,Mehrotra Rahul,Kumar Amit^ORCID,Puri Sonika,Muruganathan Arumugam,Sattur Gururaj Balvantrao,Yadav Madhur^ORCID,Singh Harinder Pal,Agarwal Rajesh Kumar,Nanda Rashmi^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference80 articles.

1. Burden of non-communicable diseases in South Asia;Ghaffar;BMJ,2004

2. Global and regional patterns in cardiovascular mortality from 1990 to 2013;Roth;Circulation,2015

3. Cardiovascular diseases in India: current epidemiology and future directions;Prabhakaran;Circulation,2016

4. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study;Yusuf;Lancet,2004

5. Asian-Indians: a review of coronary artery disease in this understudied cohort in the United States;Ardeshna;Ann Transl Med,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of proprotein convertase subtilsin /kexin 9(PCSK9) in serum of men hypertensive patients;CARDIOMETRY;2024-05-25

2. Apolipoprotein B - An ideal biomarker for atherosclerosis?;Indian Heart Journal;2024-03

3. Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments;Biomedicines;2024-02-14

4. PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders: Heralding a New Therapeutic Era and Their Future Perspectives;Current Molecular Pharmacology;2023-12

5. Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-10